Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Erlotinib-associated exacerbation of hypothyroidism with pericardial tamponade.

Kastoon T, Stump CS, Thomson SP, Yassine H.

Endocr Pract. 2012 Sep-Oct;18(5):e111-3. doi: 10.4158/EP11182.CR.

PMID:
22440982
2.

Adrenal steroids and the metabolic syndrome.

Thomson SP, Stump CS, Kurukulasuriya LR, Sowers JR.

Curr Hypertens Rep. 2007 Dec;9(6):512-9. Review.

PMID:
18367016
3.

Obesity: are we prepared to act?

Stump CS, Sowers JR, Thomson SP.

J Cardiometab Syndr. 2007 Winter;2(1):5-8. No abstract available.

PMID:
17684457
4.

Delineation of the lectin site of the molecular chaperone calreticulin.

Thomson SP, Williams DB.

Cell Stress Chaperones. 2005 Autumn;10(3):242-51.

5.

Comparing hyperlipidemia control with daily versus twice-weekly simvastatin.

Mangin EF, Robles GI, Jones WN, Ford MA, Thomson SP.

Ann Pharmacother. 2004 Nov;38(11):1789-93. Epub 2004 Oct 12.

PMID:
15479779
6.

Acute posterior multifocal placoid pigment epitheliopathy associated with adenovirus infection.

Thomson SP, Roxburgh ST.

Eye (Lond). 2003 May;17(4):542-4. No abstract available.

PMID:
12802366
7.

Inhibitors of phosphopantetheine adenylyltransferase.

Zhao L, Allanson NM, Thomson SP, Maclean JK, Barker JJ, Primrose WU, Tyler PD, Lewendon A.

Eur J Med Chem. 2003 Apr;38(4):345-9.

PMID:
12750020
8.

Predictive power of the relative lymphocyte concentration in patients with advanced heart failure.

Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ.

Circulation. 1998 Jan 6-13;97(1):19-22.

9.

Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease.

Ommen SR, Gibbons RJ, Hodge DO, Thomson SP.

Am J Cardiol. 1997 Mar 15;79(6):812-4.

PMID:
9070569
10.

Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction.

Thomson SP, Gibbons RJ, Smars PA, Suman VJ, Pierre RV, Santrach PJ, Jiang NS.

Ann Intern Med. 1995 Mar 1;122(5):335-41.

PMID:
7847644
11.

Replating efficiency of metastatic melanoma cells from lymph node and subcutaneous sites does not predict patient survival.

Meyskens FL Jr, Thomson SP, Buckmeier J.

Clin Exp Metastasis. 1989 Nov-Dec;7(6):627-32.

PMID:
2776367
12.

Leukocyte concentrations in discrimination of benign from malignant lung lesions.

Thomson SP, Kessler JF, Miller TP.

Am J Med. 1986 Jun;80(6):1035-40.

PMID:
3728502
13.
14.
15.

Kinetics of clonogenic melanoma cell proliferation and the limits on growth within a bilayer agar system.

Thomson SP, Moon TE, Meyskens FL Jr.

J Cell Physiol. 1984 Oct;121(1):114-24.

PMID:
6480705
16.

Immunohistochemical localization of actinomycin D in human melanoma tumor cells.

Hendrix MJ, Wagner HN Jr, Thomson SP, Brothman AR, Lindell TJ.

Anticancer Res. 1984 May-Jun;4(3):97-102.

PMID:
6205624
17.
18.

Potential biological explanation of stimulation of colony growth in semi-solid agar by cytotoxic agents.

Meyskens FL Jr, Thomson SP, Hickie RA, Sipes NJ.

Br J Cancer. 1983 Dec;48(6):863-8. No abstract available.

19.

Improvement of human melanoma colony formation in soft agar using boiled instead of autoclaved agar.

Thomson SP, Wright MD, Meyskens FL Jr.

Int J Cell Cloning. 1983 Jun;1(2):85-91.

PMID:
6366081
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk